|
Sourceofarticles.com
Menu |
Newest Articles
Most Viewed Articles
Sourceofarticles.com RSS
Submit Article
Login
Signup |
|
Search the articles |
|
|
|
Articles Main
Categories |
Advice
Animals
Automobiles
Business
Career
Communications
Computer Programming
Computers
Entertainment
Environment
Family
Fashion
Finance
Food
Health & Medical
Home & Garden
Humor
Internet Business
Internet Marketing
Legal
Leisure & Recreation
Marketing
Other
Politics
Reference & Education
Religion
Self Improvement
Sports
Technology & Science
Travel
Writing
|
|
Subscribe |
Receive alert message from us when new articles submitted to our site for
free.
|
|
Syndicate |
 |
|
Related Products |
NEW BOOK Fundraising Edles, L. Peter
Fundraising by Peter L. Edles (1992)
Fundraising on the Internet (1997)
NEW RelationShift: Revolutionary Fundraising - Micha...
5 hr DVD Ron Paul on Iran,Fed,Bernanke,9/11,Fundraising
NEW Board Members as Fundraising, Advisors, and Lobb...
charities, fundraising, nonprofit, grants, church
FUNDRAISING RAFFLE TICKETS W/ TICKET SOFTWARE :411208
Fundraising for Dummies
Essential Principles for Fundraising Success
The Zen of Fundraising
|
|
|
Home::Cancer
Abdominal Chemo Increases Ovarian Cancer Survival Rate
Author : David C Skul
A large clinical test shows that giving chemotherapy directly into the stomach, as well as into a vein, can improve survival of women with advanced ovarian cancer by about sixteen months. The results of the study, which pop up in this week's issue of the New England Journal of Medicine, prompted the National Cancer Institute to issue a statement supporting doctors to employ this plan of attack for appropriate patients.
Why is this new treatment reigmine so important? Ovarian cancer is the fourth greatest reason of cancer demises in women, affecting more than 22,000 women and killing more than 16,000 in 2005. Although this disease is super treatable when saw ahead of time, virtually all cases are not noticed until they have dispersed beyond the ovaries. Because so many ovarian cancer patients are diagnosed at a later stage, it is crucial to find ways to better treatments for further progressed disease.
What is already known about ovarian cancer? virtually all women with advanced ovarian cancer get chemotherapy after surgery to get rid of the tumor. That chemotherapy is usually given into a vein and moves through the bloodstream to reach tumor cells in the stomach. Doctors have also experimented with rendering the chemotherapy straight into the abdomen through a catheter, a system called intraperitoneal (IP) chemotherapy. Eight clinical trials of this approach have been done, and most showed a gain to IP chemotherapy. But this technique is not widely wore, according to the study's author, Deborah Armstrong, MD.
"There has been a prejudice against IP therapy in ovarian cancer because it's an old idea, it requires skill and experience for the surgery and for the chemotherapy, and it's additional complicated than IV chemotherapy," said Armstrong, who is a medical oncologist and associate professor at the John Hopkins Kimmel Cancer Center in Baltimore.
How this study was done: Women with stage III ovarian cancer were randomly assigned to get either standard chemotherapy in a vein (210 women), or a combination of chemotherapy in a vein and IP chemotherapy (205 women). The women had already had surgery that successfully removed all or most of the tumor; none had tumors remaining that were larger than 1 cm in diameter. All the women were treated with the same drugs, cisplatin and paclitaxel. Six cycles of chemotherapy were planned for both groups.
What was found? Women who had IP chemo operated long without their cancer coming back and lived longest overall. Women who had traditional chemotherapy in a vein survived about 4 years after treatment, while those who got chemotherapy in the stomach as well as a vein stomach an median of nearly 5 ½ years after treatment.
That improvement is "one of the largest benefits ever observed for a new therapy in gynecologic oncology," based on data from Stephen A. Cannistra, MD, who composed an editorial published with the study. He is a professor at Harvard Medical School and managing director of the division of gynecologic medical oncology at Beth Israel Deaconess Medical Center in Boston.
Nonetheless, the IP treatment was very much more difficult on the patients. Women who had this treatment had many additional terrible or life-threatening side effects, including low white blood cell counts, infection, tiredness, and anguish. Many side effects were associated to the catheters that must be introduced into the stomach to deliver the chemotherapy. These problems were so serious that fewer than half of the women designated to undergo IP chemotherapy finished all six designed treatment cycles. That makes the survival advance that good deal supplementary noteworthy, Cannistra composed.
Women who got IP therapy also reported significantly worse caliber of life during and just after treatment. By one year out, nonetheless, both groups described similar quality of life.
Discover the best alternative cancer treatments!
SEO Solutions and one way link publicity services provided by LinkAcquire.
Article Source: http://www.articledashboard.com
David C Skul - CEO LinkAcquire.com and Relativity, Inc. can provide global market exposure and solutions.
Related articles
|
More related feeds |
Abdominal+Chemo+Increases+Ovarian+Cancer+Survival+Ratehttp://blogsearch.google.com/blogsearch_feeds?hl=en&q=Abdominal+Chemo+Increases+Ovarian+Cancer+Survival+Rate&ui=blg&ie=utf-8&num=10&output=rssHow to Understand Epithelial Ovarian Cancer: Basic Knowledge of a ...
In United States, ovarian cancer killed 15520 women in 2007 and 21000 deaths are predicted for 2008 while the number of new cases is around 21600/year. In average the survival rate is below 50%. (source American Cancer Society). ...Ovarian Cancer - Causes, Symptoms and Treatment
Surgery is the preferred treatment and is often needed to diagnose ovarian cancer. Studies have shown that surgery performed by a specialist in gynecologic oncology results in a higher cure rate. Chemotherapy is used as after surgery to ... Ovarian Cancer Articles PLR - Cancer Articles
6 articles between 400 and 2100 words, including:. Abdominal Chemo Increases Ovarian Cancer Survival Rate. Ovarian Cancer & Hysterectomies - Becoming Informed About Your Options. Ovarian Cancer, Tea, and An Ounce Of Prevention ... Small Victories in the War Against Ovarian Cancer - Cancer ...
"If we can increase the rate of early diagnosis, that's probably the most likely way we're going to change the survival rate for ovarian cancer." Andersen recently led a study that boosted the level of early stage ovarian cancer ... Sleep vital to reap benefits of physical activity on cancer risk
New research shows that regular physical activity can dramatically reduce the risk of cancer as long as it is combined with adequate sleep ... Continue Reading · Uncategorized. If you enjoyed this post, please consider to leave a ... Leg Swelling (Lymphedema) in a Patient With Gynecologic Cancer ...
Tags: cancer, cancer of the vulva, cernival cancer, chemotherapy, endometrial cancer, Fallopian Tube Cancer, gynecologic cancer, immune system, leg lymphedema, leg swelling, lymph nodes, lymph vessels, lymphatic system, ovarian cancer, ... Choosing Losing: Ovarian Cancer Month
Approximately 75 percent of ovarian cancer cases are diagnosed at an advanced stage after the cancer has spread beyond the ovary. The five-year survival rate for women with ovarian cancer has not significantly increased in the past 30 ... Abdominal Chemo Increases Ovarian Cancer Survival Rate
Abdominal Chemo Increases on ovarian cancer survival RateA large clinical trial shows that giving chemotherapy directly into the stomach, and in a vein, can improve the survival of women at a stage advanced ovarian cancer by about ... Central Jersey women spread the word about ovarian cancer ...
If the illness is diagnosed and treated early, the five-year survival rate for ovarian cancer is over 90 percent. Unfortunately, due to the disease's nonspecific symptoms, less than 20 percent of all cases are found at an early stage. ... Breast Cancer and Effective Treatment - An Overview | Pharmainfo.net
Taxol is a chemotherapy drug used commonly to treat breast cancer. Its generic name is Paclitaxel. It is also used to treat ovarian, lung, prostate, bladder, melanoma, esophageal cancer and other solid tumor cancers. ...
|
|
|
|
